From the blog

Berberine and Akkermansia: What the Gut–Metabolism Research Actually Shows

Quick answers

Does berberine increase Akkermansia?
In mice, yes. Two mouse studies found berberine raised gut Akkermansia, apparently by increasing the gut's mucin production rather than by feeding the bacterium directly [7, 8]. That has not yet been shown in people.
Is dihydroberberine better absorbed than berberine?
In one pilot of five healthy young men, funded by a dihydroberberine maker, 100 mg of dihydroberberine produced about 6 to 7 times more berberine in the blood than 500 mg of standard berberine [11]. Blood sugar and insulin did not differ, and no larger trial has confirmed it.
Do Akkermansia supplements work?
Not proven. A small exploratory trial found benefits mainly with a pasteurized (non-living) form [4], and a larger 2026 trial of that form missed its main insulin-sensitivity goal [5]. Evidence for live products is thinner still [17].
Is berberine safe with medications?
Not automatically. In healthy men, berberine slowed three liver enzymes that clear many common drugs [14]. Check with your prescriber before starting it, and avoid it in pregnancy [15].

Berberine and the gut bacterium Akkermansia muciniphila come up constantly in conversations about blood sugar and midlife metabolism, often in the same breath. The short version of the research: berberine lowers HbA1c modestly in people with type 2 diabetes [12]. Its link to Akkermansia comes from mice [7, 8]. And the best human evidence for Akkermansia itself is for a pasteurized form, with mixed results [4, 5].

Here is what each piece actually rests on.

What is Akkermansia, and why does it get so much attention?

Akkermansia is a gut bacterium that feeds on mucin, the main component of the mucus layer lining the intestine [1]. In mice, obesity and diabetes go with lower Akkermansia levels, and giving the live bacterium improved metabolic markers and thickened that mucus layer [2].

In people the picture is association rather than cause. In 49 overweight or obese adults, those with higher Akkermansia at the start had better fasting glucose and responded better to a calorie-restricted diet [3]. That tells us Akkermansia tracks with metabolic health. It does not yet tell us that raising it fixes anything.

You will see Akkermansia tied to perimenopause online. I could not find direct human studies measuring it across the menopause transition, so I am not making that claim here.

Does berberine raise Akkermansia?

In mice, yes, and the mechanism is interesting. A 2021 study found berberine raised Akkermansia in a dose- and time-dependent way, yet did not make it grow when the two were simply incubated together [7]. The effect depended on the host: berberine increased the gut's mucin production and secretion, the bacterium's food supply.

A 2025 study found the same pattern in mice given a methionine- and choline-deficient diet, a standard model of fatty liver inflammation (MASH). Berberine did not boost Akkermansia directly, but it increased the mucus protein MUC2 and lowered overall bacterial load, which appeared to help Akkermansia settle in [8]. Wiping out gut bacteria with antibiotics weakened berberine's benefit, which points to the microbes as part of how it works in that model [8].

None of this has been tested in people yet. It is a plausible explanation for some of berberine's effects, not an established one.

What does berberine do for blood sugar in people?

A meta-analysis of randomized trials in type 2 diabetes found berberine lowered HbA1c by about 0.7 percentage points on average, used alone or added to standard treatment, and its authors rated the evidence strongest for berberine as an add-on [12]. My own caution: most of the trials were small, they varied in quality, and their results differed widely, so I treat this as a modest effect rather than a substitute for prescribed care.

How it works is less settled. In cell and rodent studies, berberine activates AMPK, the cell's energy sensor, and improves glucose uptake [13]. Very little of an oral dose reaches the bloodstream: in rats, about 0.36%, with roughly half passing through the gut unabsorbed [9]. That is one reason researchers suspect its effects in the gut, including on bacteria, matter.

Is dihydroberberine (DHB) worth the extra cost?

Gut bacteria convert some berberine into dihydroberberine, which in animal studies is absorbed about five times better and then converts back to berberine in the intestinal wall [10]. DHB supplements are meant to skip that conversion step.

The human evidence is one pilot study in five healthy young men, funded by a company that sells DHB [11]. In that randomized, double-blind crossover trial, 100 mg of DHB produced about 6 to 7 times more circulating berberine over two hours than 500 mg of standard berberine [11]. Blood glucose and insulin did not differ between any of the conditions, which the authors say needs testing in people who actually have glucose problems [11].

So DHB gets more berberine into the blood. Whether that leads to better blood sugar results in people is unknown. Some people hope a lower dose will be easier on the stomach, since digestive upset is the common complaint with berberine: in one small three-month pilot in type 2 diabetes, 20 patients (34.5%) had temporary digestive side effects [16]. No study has yet tested whether DHB is better tolerated.

What does the evidence say about Akkermansia supplements?

This is where the details matter most.

In a 2019 exploratory trial, 32 overweight or obese, insulin-resistant adults finished three months of placebo, live Akkermansia, or pasteurized (heat-inactivated) Akkermansia. The clearest benefits came from the pasteurized form: insulin sensitivity improved by about 29% and insulin levels dropped compared with placebo [4]. A larger 2026 trial gave 142 adults with metabolic syndrome pasteurized Akkermansia or placebo for four months and found no difference in its main insulin-sensitivity measure. A possible benefit showed up only in an exploratory analysis of people who started with low Akkermansia [5]. Two senior authors on both trials co-founded the company that develops the pasteurized product, and the 2026 trial was run largely by its staff and consultants [4, 5]. That does not make the results wrong, but it is worth knowing.

Europe's food safety agency judged the pasteurized form safe for adults in 2021 at up to 3.4 × 10^10 cells a day, excluding pregnancy and breastfeeding [6]. That opinion does not cover live products.

Many Akkermansia products on the shelf contain live bacteria. The main published trial of one tested a five-strain blend containing Akkermansia plus inulin, in adults with type 2 diabetes (76 people split across three groups); every author worked for the company that makes it [17]. After-meal blood sugar dropped modestly, right at the edge of statistical significance (p = 0.05), and HbA1c, a secondary measure, fell 0.6 points versus placebo [17]. That tells us about that blend, not about Akkermansia on its own.

Diet matters here too. A systematic review of human trials found some evidence that calorie restriction and certain fibers and supplements, including inulin, may raise Akkermansia, though few of the trials measured it [18].

Who should be careful with berberine?

Berberine is not a neutral add-on. In healthy men taking 300 mg three times a day for two weeks, it reduced the activity of CYP2D6, CYP2C9 and CYP3A4, enzymes that clear a long list of prescription drugs [14]. If you take any medication, talk to your prescriber before starting it, and be especially careful with diabetes medication, where the effects could stack.

In a test-tube study and one rat study, berberine pushed bilirubin off the protein that carries it in the blood, raising free bilirubin [15]. The author concluded it is best avoided in jaundiced newborns and in pregnancy [15]. I also do not recommend it while nursing.

Where does this leave you?

The foundations still carry the most weight: enough protein, regular movement, steady sleep, and fiber from a range of plant foods. If you and your practitioner decide berberine fits your plan, the evidence supports a modest blood-sugar effect, and DHB is an option if absorption is the concern, with the caveat that its human data is one five-person study. For Akkermansia, know which form you are buying and that the trial evidence is still mixed.

Where I source supplements

I order professional-grade products through Fullscript, including berberine and dihydroberberine formulas, and Akkermansia products for clients who want to try one after we have talked through the evidence above. If you order through my dispensary, I earn a commission on the sale. You can browse my catalog through the professional dispensary, or start from the supplements section of the Testing & Learning page.

This is education, not personal medical advice. Work with a qualified practitioner who knows your history, labs and medications before you start any new supplement.

Sources

  1. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54(Pt 5):1469-1476. pubmed.ncbi.nlm.nih.gov/15388697
  2. Everard A, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110(22):9066-9071. pubmed.ncbi.nlm.nih.gov/23671105
  3. Dao MC, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65(3):426-436. pubmed.ncbi.nlm.nih.gov/26100928
  4. Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. pubmed.ncbi.nlm.nih.gov/31263284
  5. Suenaert P, Segers A, Rymenans L, Devroye H, Moll JM, Cani PD, de Vos WM. Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut Microbes. 2026;18(1):2690689. pubmed.ncbi.nlm.nih.gov/42343233
  6. EFSA Panel on Nutrition, Novel Foods and Food Allergens. Safety of pasteurised Akkermansia muciniphila as a novel food pursuant to Regulation (EU) 2015/2283. EFSA J. 2021;19(9):6780. doi.org/10.2903/j.efsa.2021.6780
  7. Dong C, et al. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomed Pharmacother. 2021;139:111595. pubmed.ncbi.nlm.nih.gov/33862492
  8. Xu J, Lao Y, Zhang W, et al. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. J Nutr Biochem. 2025;146:110069. pubmed.ncbi.nlm.nih.gov/40816629
  9. Liu YT, et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metab Dispos. 2010;38(10):1779-1784. pubmed.ncbi.nlm.nih.gov/20634337
  10. Feng R, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 2015;5:12155. pubmed.ncbi.nlm.nih.gov/26174047
  11. Moon JM, Ratliff KM, Hagele AM, Stecker RA, Mumford PW, Kerksick CM. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia: a randomized, controlled, crossover pilot trial. Nutrients. 2021;14(1):124. pubmed.ncbi.nlm.nih.gov/35010998
  12. Guo J, et al. The effect of berberine on metabolic profiles in type 2 diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Oxid Med Cell Longev. 2021;2021:2074610. pubmed.ncbi.nlm.nih.gov/34956436
  13. Lee YS, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55(8):2256-2264. pubmed.ncbi.nlm.nih.gov/16873688
  14. Guo Y, Chen Y, Tan ZR, Klaassen CD, Zhou HH. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-217. pubmed.ncbi.nlm.nih.gov/21870106
  15. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993;63(4):201-208. pubmed.ncbi.nlm.nih.gov/8513024
  16. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. pubmed.ncbi.nlm.nih.gov/18442638
  17. Perraudeau F, et al. Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation. BMJ Open Diabetes Res Care. 2020;8(1):e001319. pubmed.ncbi.nlm.nih.gov/32675291
  18. Verhoog S, et al. Dietary factors and modulation of bacteria strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: a systematic review. Nutrients. 2019;11(7):1565. pubmed.ncbi.nlm.nih.gov/31336737

← All posts

Free — no purchase needed

Get the Companion Workbook, free.

Join the reader list and I will send you the Companion Workbook and Quick-Start Checklist. Simple tools to turn what you are reading into daily practice, before you spend a penny on anything.

You'll get the workbook and checklist right away, then an occasional grounded note about root-cause health. No spam, no selling your address, and every email has a one-click unsubscribe.